Octreotide treatment of chemotherapy-induced diarrhoea.
Ginopoulos
P
P
Papagiannis
T
T
Safridi
C
C
Karvelas
F
F
Spyropoulos
K
K
Papadas
T
T
Gogos
C
C
D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003967:Diarrhea / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*
D000964:Antimetabolites, Antineoplastic; D005765:Gastrointestinal Agents; D015282:Octreotide; D005472:Fluorouracil